GooderhamMJBolliPFernandezPG. Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin. Ann Pharmacother1999;33: 796–9.
2.
OkamuraNHiraiMTanigawaraYTanakaKYasuharaMUedaKDigoxin-cyclosporin A interaction: Modulation of the multidrug transporter P-glycoprotein in the kidney. J Pharmacol Exp Ther1993: 266:1614–9.
3.
WoodlandCVerjeeZGiesbrechtEKorenGItoS. The digoxin-propafenone interaction: Characterization of a mechanism using renal tubular cell monolayers. J Pharmacol Exp Ther1997;283: 39–45.
4.
FrommMFKimRBSteinCMWilkinsonGRRodenDM. Inhibition of P-glycoprotein-mediated drag transport: A unifying mechanism to explain the interaction between digoxin and quinidine. Circulation1999: 99:552–7.
5.
ItoSWoodlandCHarperPAKorenG. The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1). Life Sci1993;53:PL399–403.
6.
WakasugiHYanoIItoTHashidaTFutamiTNoharaREffect of clarithromycin on renal excretion of digoxin: Interaction with P-glycoprotein. Clin Pharmacol Ther1998;64:123–8.
7.
RedelmeierDANaylorCDBrennemanFDSharkeyPWTanSHJuurlinkDN. The risk of traumatic injury in elderly adults receiving lipid-lowering medications. Lancet (submitted for publication).
